BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29556234)

  • 1. The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair.
    Grčević D; Sironi M; Valentino S; Deban L; Cvija H; Inforzato A; Kovačić N; Katavić V; Kelava T; Kalajzić I; Mantovani A; Bottazzi B
    Front Immunol; 2018; 9():417. PubMed ID: 29556234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Pentraxin PTX3 in Bone Homeostasis and Pathology.
    Parente R; Sobacchi C; Bottazzi B; Mantovani A; Grčevic D; Inforzato A
    Front Immunol; 2019; 10():2628. PubMed ID: 31787987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.
    Leali D; Inforzato A; Ronca R; Bianchi R; Belleri M; Coltrini D; Di Salle E; Sironi M; Norata GD; Bottazzi B; Garlanda C; Day AJ; Presta M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):696-703. PubMed ID: 22267482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
    Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
    Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
    Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly.
    Ievoli E; Lindstedt R; Inforzato A; Camaioni A; Palone F; Day AJ; Mantovani A; Salvatori G; Salustri A
    Matrix Biol; 2011 Jun; 30(5-6):330-7. PubMed ID: 21619930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.
    Wang T; Wang Y; Menendez A; Fong C; Babey M; Tahimic CG; Cheng Z; Li A; Chang W; Bikle DD
    J Bone Miner Res; 2015 Sep; 30(9):1572-84. PubMed ID: 25801198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
    Oggioni M; Mercurio D; Minuta D; Fumagalli S; Popiolek-Barczyk K; Sironi M; Ciechanowska A; Ippati S; De Blasio D; Perego C; Mika J; Garlanda C; De Simoni MG
    Sci Rep; 2021 May; 11(1):9616. PubMed ID: 33953334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions.
    Granata V; Strina D; Schiavone ML; Bottazzi B; Mantovani A; Inforzato A; Sobacchi C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 inhibits fibroblast growth factor 2 induced osteoclastogenesis in rheumatoid arthritis.
    Zhao S; Wang Y; Hou L; Wang Y; Xu N; Zhang N
    Biomed Pharmacother; 2020 Nov; 131():110628. PubMed ID: 32890968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
    Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
    Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
    Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
    Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis.
    Maccarinelli F; Bugatti M; Churruca Schuind A; Ganzerla S; Vermi W; Presta M; Ronca R
    Front Immunol; 2021; 12():617671. PubMed ID: 33679758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
    Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
    J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility.
    Varani S; Elvin JA; Yan C; DeMayo J; DeMayo FJ; Horton HF; Byrne MC; Matzuk MM
    Mol Endocrinol; 2002 Jun; 16(6):1154-67. PubMed ID: 12040004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells.
    O'Neill CL; Guduric-Fuchs J; Chambers SE; O'Doherty M; Bottazzi B; Stitt AW; Medina RJ
    Cardiovasc Res; 2016 Dec; 112(3):677-688. PubMed ID: 27659714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection.
    Jaillon S; Moalli F; Ragnarsdottir B; Bonavita E; Puthia M; Riva F; Barbati E; Nebuloni M; Cvetko Krajinovic L; Markotic A; Valentino S; Doni A; Tartari S; Graziani G; Montanelli A; Delneste Y; Svanborg C; Garlanda C; Mantovani A
    Immunity; 2014 Apr; 40(4):621-32. PubMed ID: 24745336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production.
    Lee EJ; Song DH; Kim YJ; Choi B; Chung YH; Kim SM; Koh JM; Yoon SY; Song Y; Kang SW; Chang EJ
    J Cell Physiol; 2014 Nov; 229(11):1744-52. PubMed ID: 24664887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yin-yang of long pentraxin PTX3 in inflammation and immunity.
    Daigo K; Mantovani A; Bottazzi B
    Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.